The evolving field of biodefence: therapeutic developments and diagnostics
Identifieur interne : 004A53 ( Main/Exploration ); précédent : 004A52; suivant : 004A54The evolving field of biodefence: therapeutic developments and diagnostics
Auteurs : James C. Burnett [États-Unis] ; Erik A. Henchal [États-Unis] ; Alan L. Schmaljohn [États-Unis] ; Sina Bavari [États-Unis]Source :
- Nature Reviews Drug Discovery [ 1474-1776 ] ; 2005-04.
Abstract
The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.
Url:
DOI: 10.1038/nrd1694
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002045
- to stream Istex, to step Curation: 002045
- to stream Istex, to step Checkpoint: 001914
- to stream Main, to step Merge: 004D81
- to stream Main, to step Curation: 004A53
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The evolving field of biodefence: therapeutic developments and diagnostics</title><author><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C." last="Burnett">James C. Burnett</name></author><author><name sortKey="Henchal, Erik A" sort="Henchal, Erik A" uniqKey="Henchal E" first="Erik A." last="Henchal">Erik A. Henchal</name></author><author><name sortKey="Schmaljohn, Alan L" sort="Schmaljohn, Alan L" uniqKey="Schmaljohn A" first="Alan L." last="Schmaljohn">Alan L. Schmaljohn</name></author><author><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:493BA4E73EECB9B33043A5B849246BB294882331</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1038/nrd1694</idno><idno type="url">https://api.istex.fr/ark:/67375/GT4-G1QN2GDM-K/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002045</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002045</idno><idno type="wicri:Area/Istex/Curation">002045</idno><idno type="wicri:Area/Istex/Checkpoint">001914</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001914</idno><idno type="wicri:doubleKey">1474-1776:2005:Burnett J:the:evolving:field</idno><idno type="wicri:Area/Main/Merge">004D81</idno><idno type="wicri:Area/Main/Curation">004A53</idno><idno type="wicri:Area/Main/Exploration">004A53</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The evolving field of biodefence: therapeutic developments and diagnostics</title><author><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C." last="Burnett">James C. Burnett</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Developmental Therapeutics Program, Target Structure-Based Drug Discovery Group, National Cancer Institute-SAIC, Frederick, Maryland 21702</wicri:regionArea><wicri:noRegion>Maryland 21702</wicri:noRegion></affiliation></author><author><name sortKey="Henchal, Erik A" sort="Henchal, Erik A" uniqKey="Henchal E" first="Erik A." last="Henchal">Erik A. Henchal</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702</wicri:regionArea><wicri:noRegion>Maryland 21702</wicri:noRegion></affiliation></author><author><name sortKey="Schmaljohn, Alan L" sort="Schmaljohn, Alan L" uniqKey="Schmaljohn A" first="Alan L." last="Schmaljohn">Alan L. Schmaljohn</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702</wicri:regionArea><wicri:noRegion>Maryland 21702</wicri:noRegion></affiliation></author><author><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702</wicri:regionArea><wicri:noRegion>Maryland 21702</wicri:noRegion></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Nature Reviews Drug Discovery</title><idno type="ISSN">1474-1776</idno><idno type="eISSN">1474-1784</idno><imprint><publisher>Nature Publishing Group</publisher><date when="2005-04">2005-04</date><biblScope unit="vol">4</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="281">281</biblScope><biblScope unit="page" to="296">296</biblScope><date type="Copyright" when="2005">2005</date></imprint><idno type="ISSN">1474-1776</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1474-1776</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C." last="Burnett">James C. Burnett</name></noRegion><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name><name sortKey="Henchal, Erik A" sort="Henchal, Erik A" uniqKey="Henchal E" first="Erik A." last="Henchal">Erik A. Henchal</name><name sortKey="Schmaljohn, Alan L" sort="Schmaljohn, Alan L" uniqKey="Schmaljohn A" first="Alan L." last="Schmaljohn">Alan L. Schmaljohn</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:493BA4E73EECB9B33043A5B849246BB294882331
|texte= The evolving field of biodefence: therapeutic developments and diagnostics
}}
| This area was generated with Dilib version V0.6.33. |  |